Currently Viewing:
Currently Reading
What We're Reading: Drug Makers Sue to Block Prices in TV Ads; Opioid Settlement Proposal; Pfizer to Buy Array BioPharma
June 17, 2019 – AJMC Staff
CVS Launches Tool Enabling Pharmacists to Help Patients Save Money on Drugs
April 11, 2018 – Jaime Rosenberg
Health Policy Experts Voice Ways to Tame Rising Drug Costs, Protect Patients
April 03, 2018 – Allison Inserro
5 Healthcare Takeaways From the State of the Union
February 02, 2018 – Mary Caffrey
CVS, Novo Nordisk Launch Program for Affordable Insulin
March 20, 2017 – Mary Caffrey
Public Wants Next President, Congress to Tackle Drug Prices
October 28, 2016 – Mary Caffrey
5 Things to Know About the Walgreens-Rite Aid Deal
October 30, 2015 – Mary K. Caffrey

What We're Reading: Drug Makers Sue to Block Prices in TV Ads; Opioid Settlement Proposal; Pfizer to Buy Array BioPharma

AJMC Staff
US drug makers sue to block a federal regulation that would require them to display list prices for drugs in television advertisements; a proposal could lead to a broad settlement for opioid manufacturers that would issue a nationwide payout and prevent future lawsuits from local governments; Pfizer has agreed to buy Array BioPharma for $11.4 billion. 

US Drug Makers Sue to Prevent Display of Drug Prices in TV Ads

US drug manufacturers sued Friday to block a federal regulation from taking effect that would require them to list drug prices in television advertisements, The New York Times reported. HHS finalized the rule May 8, 2019; due to take effect in July, it represents one of the most high-profiile efforts by the Trump administration to lower prescription drug prices. Drug makers argued that list prices differ from patients' final costs, as list prices do not include rebates, discounts offered or patient assistance programs.


Proposal Could Settle All Opioid Lawsuits, Issue Nationwide Payout

Pending approval by US District Judge Dan Aaron Polster, a proposal made Friday in an Ohio federal court by lawyers for hundreds of local governments could pave the way for a nationwide settlement with opioid manufacturers, according to The New York Times. The plan could expand the number of municipalities and counties eligible for compensation in federal litigation from 1650 to nearly 24,500. The proposal was suggested to provide a greater incentive for pharmaceutical companies tthat are defendants to comprehensively settle, as it would prevent future lawsuits from local governments.


Pfizer Agrees to Acquire Array BioPharma for $11.4 Billion

In an effort to expand its presence in cancer research, Pfizer has agreed to buy Array BioPharma for $11.4 billion, paying $48 per share, The Washington Post reported. Last month, Array announced that its drugs Braftovi and Mektovi, along with another treatment, significantly improved overall survival in late-stage testing for some patients with colorectal cancer. Array planned to submit results to federal regulators later this year.

Related Articles

What We're Reading: Pfizer, GSK Combining OTC Units; NIH's Collins Under Pressure; VA Suicide Prevention Efforts Lag
HHS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads
What We're Reading: Judge Blocks Mississippi Abortion Law; Oklahoma Opioid Suit; Maine Vaccine Exemption Removal
What We're Reading: Fetal Tissue Restrictions; Opioid Maker Pays Up; Medicaid Work Requirements and Employment
What We're Reading: Missouri Abortion Clinic to Stay Open; Red Flags for Esketamine; Opioid Maker Files for Bankruptcy
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up